[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100495961":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":18,"centralContacts":22,"locations":27,"responsibleParty":57,"collaborators":17,"id":60,"slug":17,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":61,"sex":67,"minAge":68,"maxAge":17,"enrollmentInfo":69,"targetDuration":17,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":17,"overallStatus":30,"whyStopped":17,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Barbara Ann Karmanos Cancer Institute","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Tracking Dietary\u002FSupplement Intake on MyFitnessPal smartphone application (app)","MyFitnessPal smartphone application is used to track daily dietary intake and herbal\u002Falternative supplements.",[12],"Other: Tracking Dietary\u002FSupplement Intake on MyFitnessPal smartphone application (app)",[14],{"type":6,"name":9,"description":15,"armGroupLabels":16,"otherNames":17},"Amyloidosis patients will use MyFitnessPal application to track dietary intake and use of herbal\u002Falternative supplements in from week 2-9. Patient's usage of the application and questionnaires completed by the patient at the start, Week 2 and Week 10 will determine feasibility.",[9],null,[19],{"name":20,"affiliation":5,"role":21},"Jeffrey Zonder, MD","PRINCIPAL_INVESTIGATOR",[23],{"name":20,"role":24,"phone":25,"phoneExt":17,"email":26},"CONTACT","313-576-8732","zonderj@karmanos.org",[28],{"facility":29,"status":30,"city":31,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Karmanos Cancer Institute","RECRUITING","Detroit","Michigan","48201","United States","US",{"type":37,"coordinates":38},"Point",[39,40],-83.04575,42.33143,{"lat":40,"lon":39},[43,44,47,49,51,53,55],{"name":20,"role":24,"phone":25,"phoneExt":17,"email":26},{"name":45,"role":46,"phone":17,"phoneExt":17,"email":17},"Andrew Kin, M.D.","SUB_INVESTIGATOR",{"name":48,"role":46,"phone":17,"phoneExt":17,"email":17},"Navid Mahabadi, D.O.",{"name":50,"role":46,"phone":17,"phoneExt":17,"email":17},"Felicity WK Harper, PhD",{"name":52,"role":46,"phone":17,"phoneExt":17,"email":17},"Jennifer Beebe-Dimmer, PhD",{"name":54,"role":46,"phone":17,"phoneExt":17,"email":17},"Jacob Katzman",{"name":56,"role":46,"phone":17,"phoneExt":17,"email":17},"Abdul Khan, M.D.",{"type":21,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":17,"oldOrganization":17},"Jeffrey Zonder","Principal Investigator, Multiple Myeloma Multidisciplinary team leader, M.D.","100495961",false,"NCT05738005","Dietary Reporting In The Amyloidoses","DRITA Pilot Trial: Dietary Reporting in the Amyloidoses","DRITA","Inclusion Criteria:\n\n* 18 years of age or older\n* Diagnosed with any type of amyloidosis\n* Speak, read and write in English\n* Willing to use the MyFitnessPal app on their own smartphone\n\nExclusion Criteria:\n\n* a planned autologous stem cell transplant or a solid organ transplant in the 12 weeks after enrollment\n* cognitive or perceptual disturbances","ALL","18 Years",{"count":70,"type":71},40,"ESTIMATED","INTERVENTIONAL",[74],"NA","The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis.\n\nThe main question it aims to answer is:\n\nIs it feasible to use a low-cost nutrition-based application (apps) for use on a smartphone to obtain detailed information on caloric intake in Amyloidosis patients\n\nParticipants will be asked to:\n\n* Download the MyFitnessPal application on their smartphone and view an online tutorial\n* After a week of practice, from weeks 2-9, participants will enter daily dietary intake as well as daily herbal\u002Falternative supplement intake into the MyFitnessPal application on their smartphone.\n* complete a questionnaire prior to starting the application, after week 2 and at week 10 after starting the application",[77],"Amyloidosis","2026-06-23",{"date":80,"type":81},"2026-06-26","ACTUAL",{"date":83,"type":81},"2023-03-02",{"date":85,"type":71},"2028-11-21",{"name":5,"class":6},1]